Skip to main content
. 2019 Sep 6;11(9):1316. doi: 10.3390/cancers11091316

Figure 5.

Figure 5

Somatic variants detected by amplicon sequencing in primary TGCT tumors (in comparison to germ-line control patient samples)—variants present in at least 20% of sequencing reads.